News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Status Regarding Novo Nordisk A/S (NVO)'s Holding of Its Own Shares (31 December 2012)


1/2/2013 8:44:43 AM

BAGSVAERD, DENMARK--(Marketwire - January 02, 2013) - In continuation of the company's announcements dated 9 August 2012 and 9 November 2012 concerning planned share repurchase programmes, and pursuant to Section 204.25 of the New York Stock Exchange Listed Company Manual, this is to report that Novo Nordisk A/S (NYSE: NVO) and its wholly-owned affiliates on 31 December 2012 owned 17,416,676 of its own B shares of DKK 1, corresponding to a total nominal value of DKK 17,416,676 or 3.1% of the total share capital.

Company announcement No 02 / 2013: http://hugin.info/2013/R/1667832/541468.pdf

This announcement is distributed by Thomson Reuters on behalf of Thomson Reuters clients. The owner of this announcement warrants that:

(i) the releases contained herein are protected by copyright and other applicable laws; and

(ii) they are solely responsible for the content, accuracy and originality of the information contained therein.

Source: Novo Nordisk A/S via Thomson Reuters ONE

[HUG#1667832]


Further information
Media:
Anne Margrethe Hauge
+45 4442 3450
Email Contact

Ken Inchausti (US)
+1 609 514 8316
Email Contact

Investors:
Kasper Roseeuw Poulsen
+45 4442 4303
Email Contact

Frank Daniel Mersebach
+45 4442 0604
Email Contact

Lars Borup Jacobsen
+45 3075 3479
Email Contact

Jannick Lindegaard (US)
+1 609 786 4575
Email Contact


Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES